This model incorporates seven variables, including pathological stage, tumor size, the number of total lymph nodes, the number of metastatic lymph nodes, intraoperative blood loss (IBL), and levels of AFP and CA199, enabling rapid assessment of patients’ risk of recurrence (59). The gene discussed is AFP; the disease is neoplasm.